Adriana Bastos Carvalho

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biofísica Carlos Chagas Filho

Departamento:

Serviço de Biofísica Celular/I Biof

ORCID:

https://orcid.org/0000-0002-7830-7868


Formação:
  • University of Toronto

    | Pós-Doutorado | 2012 - 2013
  • Instituto de Biofísica Carlos Chagas Filho

    | Pós-Doutorado | 2009 - 2010
  • Brigham and Women?s Hospital, Harvard Med.School

    | Pós-Doutorado | 2008 - 2009
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Fisiologia) | Doutorado | 2006 - 2008
  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 2002 - 2007
Laboratórios:
Nuvens de Palavras:
Artigos:
Nenhum artigo cadastrado
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Investigação dos mecanismos moleculares da síndrome do QT longo do tipo 2 utilizando cardiomiócitos derivados de iPSC 2017
Medicina personalizada na SQTL1: geração in vitro de cardiomiócitos paciente-específicos 2017
Investigating molecular mechanisms of type 2 long QT syndrome with iPSC-derived cardiomyocytes 2017
Investigating molecular mechanisms of type 2 long QT syndrome with iPSC-derived cardiomyocytes 2017
The impact of diabetes mellitus on miR expression of patients with or without heart failure 2016
Cell therapy with cardiomyocytes derived from embryonic stem cells in doxorubicin-induced cardiomyopathy model 2016
Hypoxia and serum deprivation do not impair cellular viability, proliferation capacity and anti-oxidant enzyme expression in mesenchymal stem cells derived from menstrual blood 2015
Improvement of cardiac function by embryonic stem cell derived cardiomyocytes in doxorubicin induced cardiomyopathy model 2015
Evaluation of cell therapy in experimental model of Chagas disease using magnetic resonance imaging and single photon emission computed tomography 2015
Cell therapy using bone marrow mesenchymal stem cells in a canine model of chagasic cardiomyopathy 2015
Engineering extracellular matrix for liver transplantation 2015
Uma nova perspectiva para o estudo da síndrome do QT longo: geração de células-tronco pluripotentes induzidas paciente-específicas 2015
Embryonic stem cell-derived cardiomyocytes increase viable myocardium but do not improve function in a mouse model of chagasic cardiomyopathy 2015
Mesenchymal stem cells derived from menstrual blood survive and proliferate in extreme condition of hypoxia and serum deprivation 2015
Mice hearts infected with Trypanosoma cruzi: functional and morphological evaluation 2015
Characterization of cardiac progenitor cells and evaluation of their therapeutic potential in a murine model of healed myocardial infarction 2014
Generation and cardiac differentiation of feeder free induced pluripotent stem cells 2014
Cardiomyocytes derived from mouse embryonic stem cells improve cardiac function in doxorubicin-induced cardiomyocyte 2014
Cell therapy using bone marrow mesenchymal stem cells in a canine model of chagasic cardiomyopathy 2014
Evaluation of the correlation between CD56, KDR and PDGFRa expression in embryonic stem cell differentiation to cardiomyocytes 2014
Altered expression of miR-29a and your possible target, KCNIP2, in diabetic patients 2014
Use of magnetic resonance imaging and single photon emission computed tomography for evaluation of cell therapy in experimental model of Chagas disease 2014
miR-208a-3p is Downregulated in Cardiac Remodeling and Possibly Controls Gata4 Expression 2013
Reprogramming of oxidative stress responses in human induced pluripotent stem cells derived from menstrual blood 2013
Hepatic Cells: An Alternative Source to Repopulate The Bioartificial Liver 2012
Reprogramming to a Pluripotent State Modifies Menstrual Blood-Derived Mesenchymal Stem Cell Resistance to Oxidative Stress 2012
Functional and Transcriptomic Recovery of Infarcted Mouse Myocardium Treated with Bone Marrow Mononuclear Cells 2011
Characterization of cells from human amniotic fluid and evaluating their potential to differentiate into cardiomyocytes 2011
Development of Chagasic Cardiomyopathy Model in Chimeric Mice 2011
HUMAN MENSTRUAL BLOOD-DERIVED MESENCHYMAL CELLS: CHARACTERIZATION AND EVIDENCE FOR ENHANCED RESISTANCE AGAINST OXIDATIVE STRESS 2011
PRELIMINARY STUDY OF MOUSE EMBRYONIC STEM CELL TRANSPLANTATION IN MICE EXPERIMENTALLY INFECTED WITH T. cruzi 2011
Radiation-Induced Liver Damage in Mice: an Experimental Model to Study Tissue Regeneration 2011
Adipose tissue mesenchymal cells prevent late right ventricular dilatation in an experimental model of chronic chagasic cardiomyopathy 2011
Development of a chagasic cardiomyopathy model in chimeric mice 2011
Cardiac differentiation of human umbilical cord-derived stromal cells 2011
Bone marrow transplantation: what is the best delivery site for engraftment in mice? 2011
Evaluation of growth factors produced by human menstrual blood-derived mesenchymal stem cells for the maintenance of human embryonic stem cells 2011
Menstrual blood-derived stem cells are not impaired by oral contraceptives 2011
Bone marrow-derived cells migrate to liver post partial hepatectomy in chimeric mice 2010
Human hair follicle feeder-layers support undiferentiated growth of human embryonic stem cells 2010
Human menstrual blood derived mesenchymal cells are an alternative feeder-layer for human embryonic stem cells 2010
A comparative study of human fetal extra-embryonic mesenchymal stem cells 2010
Cardiomyocyte differentiation of human amniotic fluid-derived mesenchymal cells 2010
Cardiosphere-derived cells have a mesenchymal phenotype and express contractile molecules when co-cultured with neonatal cardiomyocytes 2010
Safety and feasibility of intramyocardial injection of mesenchymal stem cells derived from the placenta and umbilical cord in an experimental model of chronic Chagas? disease cardiomyopathy 2010
Decellularized rat hearts: one step toward generating a bioartificial heart 2010
Effects of Trypanosoma cruzi infection in human cardiac progenitor cells 2010
Mouse mesenchymal stromal cells can be more efficiently isolated from compact bone than from bone marrow 2010
Human menstrual blood and hair follicle derived mesenchymal cells are alternative feeder-layers for mouse and human embryonic stem cells 2010
Infection with Trypanosoma cruzi does not promote apoptosis in human cardiac progenitor cells 2010
Transplantation of placenta-derived mesenchymal stem cells in immunocompetent mice submitted to myocardial infarction 2010
Cardiosphere-derived cells: new perspective in cardiac cell therapy 2010
Cell therapy using human placenta-derived cells in a murine model of Chagas? disease 2010
Placenta-derived mesenchymal stromal cells in myocardial infarction therapy: preliminary results 2010
Stem cells amniotic fluid-derived might be considered an alternative source of stem cells for cardiac cell therapy 2010
Characterization of human menstrual blood-derived mesenchymal cells and detection by bioluminescence imaging in vivo 2010
Development of natural 3D scaffold for stem cell therapies studies 2010
Effects of mouse adipose tissue-derived mesenchymal cells in as experimental model of chagasic cardiomyopathy 2010
Mouse embryonic stem cell transplantation in mice experimentally infected with T. cruzi: preliminary results 2010
CHARACTERIZATION OF CARDIAC PROGENITOR CELLS FROM HUMAN ADULT MYOCARDIUM 2009
CHARACTERIZATION OF PLACENTA DERIVED STEM CELLS 2009
EXPRESSION OF CARDIAC-SPECIFIC GENES BY MULTIPOTENT HUMAN AMNIOTIC FLUID-DERIVED 2009
HAIR FOLLICLE-DERIVED CELLS ARE AN ALTERNATIVE FEEDER-LAYER FOR EMBRYONIC STEM 2009
INTERACTION BETWEEN TRYPANOSOMA CRUZI AND CARDIAC PROGENITOR CELLS: ANALYSIS OF 2009
ISOLATION AND CHARACTERIZATION OF BONE MARROW-DERIVED MESENCHYMAL STEM CELLS 2009
ISOLATION AND CHARACTERIZATION OF HUMAN UMBILICAL CORD STROMAL CELLS 2009
MENSTRUAL BLOOD-DERIVED MESENCHYMAL CELLS: AN ALTERNATIVE FEEDER-LAYER FOR 2009
MENSTRUAL BLOOD-DERIVED MESENCHYMAL CELLS: NEW PROGENITOR CELL SOURCE FOR STEM 2009
SAFETY OF NON-INVASIVE INTRAMYOCARDIAL INJECTION OF MESENCHYMAL STEM CELLS IN MICE 2009
The Turnover of Cardiac Progenitor Cells is Modulated by the Level of p53 Expression 2008
Mutations of c-kit Receptor are Coupled with Impaired Growth and Enhanced Death of Cardiac Progenitor Cells 2008
MicroRNA-499 Promotes the Differentiation of Cardiac Progenitor Cells into Myocytes 2008
IGF-1, Angiotensin II and Human Cardiac Progenitor Cell Function 2008
Asymmetric Division of Human Cardiac Progenitor Cells Involves Immortal DNA Strand Cosegregation 2008
Doxorubicin-Induced Cardiomyopathy Is Partially Reversed by Cardiac Progenitor Cell Therapy 2008
Myocyte Formation by Cardiac Progenitor Cells is Regulated by Micro-RNAs 2008
Human Cardiac Progenitor Cells Divide Symmetrically and Asymmetrically 2008
Bone Marrow Mesenchymal Cells Do Not Reduce Fibrosis or Improve Function in a Rat Model of Chronic Liver Injury 2007
Bone Marrow Stem Cell Therapy on an Experimental Model of Cirrhosis 2006
Blood Markers in the Diagnostic Evaluation of an Experimental Model in Rats 2005
Macro and Microscopic Analysis of a Cirrhosis Experimental Model in Rats 2005
Ultrasound Assessment to Study the Development of an Experimental Cirrhosis Model in Rats 2005
Modelo Animal de Cirrose Hepática em Camundongos Induzida por Injeção Intraperitonial de Tetraclotreto de Carbono 2003
Publicações:
Minha Rede: